Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
Source: MedTech Dive
You may also like
Knee Pain? Ragged Cartilage? Research Suggests...
Lawmakers Look To Make Abortion Shield Laws Less...
HistoSonics wins Europe’s CE mark for...
Medtronic recalls heart valve delivery catheter for...
CVS Caremark reaches settlement with FTC over insulin...
HCA cuts 2026 earnings forecast on insurance coverage...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.